Intellia Therapeutics
NTLA
$21.57
Share price
1.17%
Change (1 day)
-42.56%
Change (1 year)
P/S ratio for Intellia Therapeutics (NTLA)
P/S ratio as of April 2024 (TTM): 56.5
According to Intellia Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 56.4849. At the end of 2023 the company had a P/S ratio of 75.3.
P/S ratio history for Intellia Therapeutics from 2016 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 75.3 | 30.42% |
| 2022 | 57.7 | -78.32% |
| 2021 | 266 | 339.37% |
| 2020 | 60.6 | 254.65% |
| 2019 | 17.1 | -15.77% |
| 2018 | 20.3 | -34.9% |
| 2017 | 31.2 | 8.8% |
| 2016 | 28.6 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |